volume 28 issue 1 pages 51-59

Cystinosis: the evolution of a treatable disease

Publication typeJournal Article
Publication date2012-08-18
scimago Q1
wos Q1
SJR0.870
CiteScore5.0
Impact factor2.6
ISSN0931041X, 1432198X
Nephrology
Pediatrics, Perinatology and Child Health
Abstract
Cystinosis is a rare autosomal recessive disorder involving lysosomal storage of the amino acid cystine due to a defect in the membrane transport protein, cystinosin. Since the introduction of kidney transplants and the availability of cystine-depleting medical therapy, this previously fatal disease was transformed into a treatable disorder. Renal allografts and medical therapy targeting the basic metabolic defect have altered the natural hisotry of cystinosis so drastically that patients have a life expectancy extending past 50 years. Consequently, early diagnosis and appropriate therapy are critically important. In this article, we offer a review of the manifestations of cystinosis, including the proximal tubular dysfunction of renal Fanconi syndrome, and discuss the prevention and treatment of the disorder’s systemic complications. We focus on the nephropathic forms of cystinosis, aiming to assist nephrologists and other physicians to develop early recognition and appropriate management of cystinosis patients.
Found 
Found 

Top-30

Journals

2
4
6
8
10
12
14
Pediatric Nephrology
14 publications, 9.79%
Cells
4 publications, 2.8%
Orphanet Journal of Rare Diseases
4 publications, 2.8%
BMC Nephrology
4 publications, 2.8%
Klinische Monatsblatter fur Augenheilkunde
4 publications, 2.8%
Kidney International
3 publications, 2.1%
Journal of Inherited Metabolic Disease
3 publications, 2.1%
JIMD Reports
3 publications, 2.1%
Nephrology Dialysis Transplantation
3 publications, 2.1%
International Journal of Molecular Sciences
2 publications, 1.4%
Pharmaceutics
2 publications, 1.4%
CEN Case Reports
2 publications, 1.4%
Egyptian Pediatric Association Gazette
2 publications, 1.4%
Ophthalmology and Therapy
2 publications, 1.4%
Molecular Genetics and Metabolism Reports
2 publications, 1.4%
Expert Opinion on Orphan Drugs
2 publications, 1.4%
Journal of the American Society of Nephrology : JASN
2 publications, 1.4%
CKJ: Clinical Kidney Journal
2 publications, 1.4%
British Journal of Ophthalmology
2 publications, 1.4%
Journal of Pediatric Endocrinology and Metabolism
2 publications, 1.4%
American Journal of Physiology - Renal Physiology
2 publications, 1.4%
Journal of Rare Diseases
2 publications, 1.4%
Frontiers in Pediatrics
2 publications, 1.4%
Journal of the Society for Social Work and Research
1 publication, 0.7%
Pediatrics in Review
1 publication, 0.7%
Antioxidants and Redox Signaling
1 publication, 0.7%
NEJM Catalyst
1 publication, 0.7%
Biochemical Society Transactions
1 publication, 0.7%
Pediatric and Developmental Pathology
1 publication, 0.7%
2
4
6
8
10
12
14

Publishers

5
10
15
20
25
30
35
40
45
Springer Nature
45 publications, 31.47%
Elsevier
26 publications, 18.18%
MDPI
11 publications, 7.69%
Oxford University Press
8 publications, 5.59%
Wiley
5 publications, 3.5%
Georg Thieme Verlag KG
4 publications, 2.8%
Taylor & Francis
4 publications, 2.8%
BMJ
3 publications, 2.1%
Frontiers Media S.A.
3 publications, 2.1%
Ovid Technologies (Wolters Kluwer Health)
2 publications, 1.4%
American Society of Nephrology
2 publications, 1.4%
Walter de Gruyter
2 publications, 1.4%
American Physiological Society
2 publications, 1.4%
Medknow
2 publications, 1.4%
S. Karger AG
2 publications, 1.4%
University of Chicago Press
1 publication, 0.7%
American Academy of Pediatrics
1 publication, 0.7%
Mary Ann Liebert
1 publication, 0.7%
Massachusetts Medical Society
1 publication, 0.7%
Portland Press
1 publication, 0.7%
SAGE
1 publication, 0.7%
Public Library of Science (PLoS)
1 publication, 0.7%
Portico
1 publication, 0.7%
Cambridge University Press
1 publication, 0.7%
SciELO
1 publication, 0.7%
Cold Spring Harbor Laboratory
1 publication, 0.7%
Scientific Scholar
1 publication, 0.7%
Spandidos Publications
1 publication, 0.7%
5
10
15
20
25
30
35
40
45
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
143
Share
Cite this
GOST |
Cite this
GOST Copy
Nesterova G., Gahl W. A. Cystinosis: the evolution of a treatable disease // Pediatric Nephrology. 2012. Vol. 28. No. 1. pp. 51-59.
GOST all authors (up to 50) Copy
Nesterova G., Gahl W. A. Cystinosis: the evolution of a treatable disease // Pediatric Nephrology. 2012. Vol. 28. No. 1. pp. 51-59.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1007/s00467-012-2242-5
UR - https://doi.org/10.1007/s00467-012-2242-5
TI - Cystinosis: the evolution of a treatable disease
T2 - Pediatric Nephrology
AU - Nesterova, Galina
AU - Gahl, William A.
PY - 2012
DA - 2012/08/18
PB - Springer Nature
SP - 51-59
IS - 1
VL - 28
PMID - 22903658
SN - 0931-041X
SN - 1432-198X
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2012_Nesterova,
author = {Galina Nesterova and William A. Gahl},
title = {Cystinosis: the evolution of a treatable disease},
journal = {Pediatric Nephrology},
year = {2012},
volume = {28},
publisher = {Springer Nature},
month = {aug},
url = {https://doi.org/10.1007/s00467-012-2242-5},
number = {1},
pages = {51--59},
doi = {10.1007/s00467-012-2242-5}
}
MLA
Cite this
MLA Copy
Nesterova, Galina, and William A. Gahl. “Cystinosis: the evolution of a treatable disease.” Pediatric Nephrology, vol. 28, no. 1, Aug. 2012, pp. 51-59. https://doi.org/10.1007/s00467-012-2242-5.